MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone

Histology and Histopathology

Volumn 28, Issue 5, 2013, Pages 671-678

  Mosakhani, Neda ^a   Pazzaglia, Laura ^b   Serena Benassi, Maria ^b   Borze, Ioana ^a   Quattrini, Irene ^b   Picci, Piero ^b   Knuutila, Sakari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Giant cell tumor of bone; Metastatic; miRNA; mRNA

Indexed keywords

MICRORNA; MIRN136 MICRORNA, HUMAN; NFIB PROTEIN, HUMAN; NUCLEAR FACTOR I; TUMOR MARKER;

ADULT; ARTICLE; BONE TUMOR; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; INCIDENCE; LUNG TUMOR; MALE; METABOLISM; METASTASIS; OSTEOCLASTOMA; PATHOLOGY; PROGNOSIS; RISK FACTOR;

ADULT; BONE NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GIANT CELL TUMOR OF BONE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MICRORNAS; NEOPLASM METASTASIS; NFI TRANSCRIPTION FACTORS; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877135394     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Arndt G.M., Dossey L., Cullen L.M., Lai A., Druker R., Eisbacher M., Zhang C., Tran N., Fan H., Retzlaff K., Bittner A. and Raponi M. (2009). Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9, 374.
2. Bartel D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
3. Bennett G., Sadlier D., Doran P.P., Macmathuna P. and Murray D.W. (2011). A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer. BMC Cancer 11, 50.
4. Betel D., Wilson M., Gabow A., Marks D.S. and Sander C. (2008). The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149-153.
5. Bray I., Tivnan A., Bryan K., Foley N.H., Watters K.M., Tracey L., Davidoff A.M. and Stallings R.L. (2011). MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma. Cancer Lett. 303, 56-64.
6. Conti A., Rodriguez G.C., Chiechi A., Blazquez R.M., Barbado V., Krenacs T., Novello C., Pazzaglia L., Quattrini I., Zanella L., Picci P., De Alava E. and Benassi M.S. (2011). Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis. Am. J. Pathol. 178, 88-97.
7. Dooley A.L., Winslow M.M., Chiang D.Y., Banerji S., Stransky N., Dayton T.L., Snyder E.L., Senna S., Whittaker C.A., Bronson R.T., Crowley D., Barretina J., Garraway L., Meyerson M. and Jacks T. (2011). Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev. 25, 1470-1475.
8. Esquela-Kerscher A. and Slack F.J. (2006). Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
9. Gamberi G., Benassi M.S., Bohling T., Ragazzini P., Molendini L., Sollazzo M.R., Merli M., Ferrari C., Magagnoli G., Bertoni F. and Picci P. (1998). Prognostic relevance of C-myc gene expression in giant-cell tumor of bone. J. Orthop. Res. 16, 1-7.
10. Gamberi G., Benassi M.S., Ragazzini P., Pazzaglia L., Ponticelli F., Ferrari C., Balladelli A., Mercuri M., Gigli M., Bertoni F. and Picci P. (2004). Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone. Ann. Oncol. 15, 498-503.
11. Griffiths-Jones S., Saini H.K., van Dongen S. and Enright A.J. (2008). miRBase: tools for microRNA genomics. Nucleic Acids Res. 36, D154-D158.
12. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Menard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M. and Croce C.M. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065-7070.
13. Kashima T.G., Dongre A., Flanagan A.M., Hogendoorn P.C., Taylor R. and Athanasou N.A. (2011). Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia. Virchows Arch. 459, 41-46.
14. Lebanony D., Benjamin H., Gilad S., Ezagouri M., Dov A., Ashkenazi K., Gefen N., Izraeli S., Rechavi G., Pass H., Nonaka D., Li J., Spector Y., Rosenfeld N., Chajut A., Cohen D., Aharonov R. and Mansukhani M. (2009). Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small- cell lung carcinoma. J. Clin. Oncol. 27, 2030-2037.
15. Leone V., D'Angelo D., Rubio I., de Freitas P.M., Federico A., Colamaio M., Pallante P., Medeiros-Neto G. and Fusco A. (2011). MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1a. J. Clin. Endocrinol. Metab. 96, E1388-E1398.
16. Lewis B.P., Burge C.B. and Bartel D.P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
17. Leyden J., Murray D., Moss A., Arumuguma M., Doyle E., McEntee G., O'Keane C., Doran P. and MacMathuna P. (2006). Net1 and Myeov: computationally identified mediators of gastric cancer. Br. J. Cancer 94, 1204-1212.
18. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S. and Johnson J.M. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773.
19. Lulla R.R., Costa F.F., Bischof J.M., Chou P.M., de F Bonaldo M., Vanin E.F. and Soares M.B. (2011). Identification of differentially expressed microRNAs in osteosarcoma. Sarcoma 2011, 732690.
20. Ma L., Teruya-Feldstein J. and Weinberg R.A. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688.
21. Mattie M.D., Benz C.C., Bowers J., Sensinger K., Wong L., Scott G.K., Fedele V., Ginzinger D., Getts R. and Haqq C. (2006). Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer 5, 24.
22. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T. and Patel T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658.
23. Moon H.G., Hwang K.T., Kim J.A., Kim H.S., Lee M.J., Jung E.M., Ko E., Han W. and Noh D.Y. (2011). NFIB is a potential target for estrogen receptor-negative breast cancers. Mol. Oncol. 5, 538-544.
24. Mosakhani N., Guled M., Lahti L., Borze I., Forsman M., Paakkonen V., Ryhanen J. and Knuutila S. (2010). Unique microRNA profile in Dupuytren's contracture supports deregulation of beta-catenin pathway. Mod. Pathol. 23, 1544-1552.
25. Nohata N., Sone Y., Hanazawa T., Fuse M., Kikkawa N., Yoshino H., Chiyomaru T., Kawakami K., Enokida H., Nakagawa M., Shozu M., Okamoto Y. and Seki N. (2011). miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2, 29-42.
26. Pazzaglia L., Conti A., Chiechi A., Novello C., Magagnoli G., Astolfi A., Pession A., Krenacs T., Alberghini M., Picci P. and Benassi M.S. (2010). Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases. Histopathology 57, 59-72.
27. Reid R., Banerjee S.S. and Sciot R. (2002).Giant cell tumour. In: Pathology and genetics: Tumours of soft tissue and bone. Fletcher C.D.M, Unni K.K. and Mertens F. (eds). IARC Press. Lyon. pp 310-312.
28. Schulte J.H., Marschall T., Martin M., Rosenstiel P., Mestdagh P., Schlierf S., Thor T., Vandesompele J., Eggert A., Schreiber S., Rahmann S. and Schramm A. (2010). Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma. Nucleic Acids Res. 38, 5919-5928.
29. Smith L.T., Mayerson J., Nowak N.J., Suster D., Mohammed N., Long S., Auer H., Jones S., McKeegan C., Young G., Bos G., Plass C. and Morrison C. (2006). 20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome. Genes Chromosomes Cancer. 45, 957-966.
30. Whichard Z.L., Motter A.E., Stein P.J. and Corey S.J. (2011). Slowly produced microRNAs control protein levels. J. Biol. Chem. 286, 4742-4748.
31. Wolf R.E. and Enneking W.F. (1996). The staging and surgery of musculoskeletal neoplasms. Orthop. Clin. North Am. 27, 473-481.
32. Wulling M., Delling G. and Kaiser E. (2003). The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum. Pathol. 34, 983-993.
33. Yoon S., Choi Y.C., Lee S., Jeong Y., Yoon J. and Baek K. (2010). Induction of growth arrest by miR-542-3p that targets survivin. FEBS Lett. 584, 4048-4052.